Press release
Chronic Disease Management Market Set to Surge to $14.88 Billion by 2031 at a 11.8% CAGR
In 2021, the global Chronic Disease Management Market was valued at approximately $4.90 billion. Projections indicate a significant expansion, with expectations to reach $14.88 billion by 2031. This anticipated growth corresponds to a CAGR of 11.8% from 2022 to 2031. Chronic diseases, defined as conditions lasting a year or more and requiring ongoing medical attention, have become a significant global health concern. These ailments, including heart disease, hypertension, chronic respiratory diseases, diabetes, asthma, stroke, and cancer, not only diminish the quality of life for individuals but also impose substantial economic burdens on healthcare systems worldwide. The escalating prevalence of these conditions has led to the emergence and rapid growth of the Chronic Disease Management Market, which focuses on integrated care approaches encompassing screenings, regular check-ups, treatment monitoring, coordination, and patient education to manage these illnesses effectively.Read More: https://www.alliedmarketresearch.com/chronic-disease-management-market-A12327
Growth Factors
Several key factors are propelling the expansion of the Chronic Disease Management Market:
1. Aging Population: The global increase in the elderly population contributes to a higher incidence of chronic diseases, thereby amplifying the demand for effective management solutions.
2. Rising Prevalence of Chronic Diseases: Lifestyle changes, unhealthy diets, physical inactivity, and harmful habits such as tobacco and alcohol use have led to a surge in chronic conditions. According to the World Health Organization (WHO), non-communicable diseases (NCDs) affect individuals across all age groups and regions, accounting for a significant portion of the global disease burden.
3. Integration of IT Solutions: The incorporation of information technology into healthcare has enhanced the efficiency of chronic disease management. Digital tools facilitate better patient monitoring, data management, and personalized care plans, thereby improving patient outcomes.
4. Strategic Initiatives by Key Players: Leading companies are engaging in mergers, collaborations, and acquisitions to expand their product offerings and geographical reach, thereby driving market growth.
Market Segmentation
The Chronic Disease Management Market is segmented based on type, disease type, end user, and region.
By Type:
- Solutions: This segment is further divided into on-premise and cloud-based solutions. In 2021, solutions held the largest market share, driven by increased awareness and adoption of these technologies in healthcare settings.
- Services: Comprising educational, implementation, and consulting services, this segment is experiencing rapid growth due to the rising incidence of chronic diseases and the subsequent need for comprehensive management strategies.
By Disease Type:
- Diabetes: This segment accounted for the highest revenue in 2021, attributed to the global rise in diabetes prevalence stemming from lifestyle factors and obesity.
- Cardiovascular Diseases: Projected to be the fastest-growing segment, driven by an increase in conditions such as stroke, aortic aneurysm, and arrhythmia.
- Cancer, Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others: These segments also contribute significantly to the market, reflecting the broad spectrum of chronic diseases requiring management.
By End User:
- Healthcare Providers: Dominated the market in 2021, as the rising prevalence of chronic diseases necessitates enhanced healthcare services and management systems.
- Payers and Others: These segments are also integral to the market, with payers focusing on cost-effective management solutions and other stakeholders contributing to comprehensive care delivery.
Get Sample PDF Copy Here: https://www.alliedmarketresearch.com/request-sample/A12327
By Region:
- North America: Held the largest market share in 2021, attributed to a high prevalence of chronic diseases and advanced healthcare infrastructure.
- Asia-Pacific: Anticipated to experience the fastest growth during the forecast period, driven by increasing healthcare investments, rising awareness, and a growing geriatric population.
- Europe and LAMEA (Latin America, Middle East, and Africa): These regions also contribute to the market, with varying growth rates influenced by healthcare infrastructure and disease prevalence.
Key Players
Prominent companies operating in the Chronic Disease Management Market include:
- ZeOmega
- Health Catalyst
- Pegasystems Inc.
- Cognizant
- Allscripts Healthcare, LLC
- Koninklijke Philips N.V.
These organizations are at the forefront of developing innovative solutions and services to enhance chronic disease management, thereby contributing to market growth.
The Chronic Disease Management Market is poised for substantial growth, driven by factors such as an aging global population, increasing prevalence of chronic diseases, technological advancements, and strategic initiatives by key industry players. As healthcare systems worldwide continue to prioritize effective management of chronic conditions, the demand for integrated care approaches is expected to rise, further propelling market expansion.
Procure Complete Report Here: https://www.alliedmarketresearch.com/checkout-final/0b2471121ccaf4d504f21f2c7f7e3bf1?utm_source=Nilesh.Musale
Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.
Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Disease Management Market Set to Surge to $14.88 Billion by 2031 at a 11.8% CAGR here
News-ID: 3979514 • Views: …
More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…

Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…

Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…

Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…